PR1211 : Prostate adenocarcinoma with hyperplasia and prostate tissue array, including pathology grade, TNM, clinical stage (AJCC 8.0), Gleason grade and Gleason score, 121 cases/121 cores, replaced by PR1211a
|
Microarray Panel | Prostate adenocarcinoma with hyperplasia and prostate tissue microarray, containing 100 cases of adenocarcinoma, 3 leiomyosarcoma, 7 simple hyperplasia, 5 cancer adjacent prostate tissue, 6 prostate tissue, single core per case | |
Cores | 121 | |
Cases | 121 | |
Row number | 10 | |
Column number | 13 | |
Core Diameter (mm) | 1.5 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Pro - Prostate - , - AT, - Hyperplasia, - , - , - , - , - , - , - , - , - , - , - Normal tissue |
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Gleason Score | Gleason Grade | Image |
---|
A1 | 1 | 62 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+2 | 1 | ||
A2 | 2 | 72 | M | Prostate | Adenocarcinoma | - | - | Malignant | 2+3 | 1 | ||
A3 | 3 | 61 | M | Prostate | Adenocarcinoma | - | - | Malignant | 2+2 | 1 | ||
A4 | 4 | 66 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+3 | 1 | ||
A5 | 5 | 58 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+2 | 1 | ||
A6 | 6 | 58 | M | Prostate | Adenocarcinoma | - | - | Malignant | 2+3 | 1 | ||
A7 | 7 | 79 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+4 | 1 | ||
A8 | 8 | 77 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+3 | 1 | ||
A9 | 9 | 64 | M | Prostate | Adenocarcinoma (blank) | T2N0M0 | IIA | Malignant | 2+3 | 1 | ||
A10 | 10 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+4 | 1 | ||
A11 | 11 | 78 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 3+3 | 1 | ||
A12 | 12 | 64 | M | Prostate | Adenocarcinoma | T2N0M1 | IIA | Malignant | 2+3 | 1 | ||
A13 | 13 | - | - | - | - | - | - | - | - | - | ||
B1 | 14 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+3 | 1 | ||
B2 | 15 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 3+2 | 1 | ||
B3 | 16 | 63 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 3+4 | 2 | ||
B4 | 17 | 64 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIB | Malignant | 3+3 | 1 | ||
B5 | 18 | 74 | M | Prostate | Adenocarcinoma | T4N1M1 | IVB | Malignant | 2+3 | 1 | ||
B6 | 19 | 85 | M | Prostate | Adenocarcinoma | T3N0M0 | III | Malignant | 2+2 | 1 | ||
B7 | 20 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+4 | 1 | ||
B8 | 21 | 76 | M | Prostate | Adenocarcinoma | T2N0M0 | IIA | Malignant | 2+3 | 1 | ||
B9 | 22 | 90 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+4 | 2 | ||
B10 | 23 | 64 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+4 | 2 | ||
B11 | 24 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
B12 | 25 | 61 | M | Prostate | Adenocarcinoma (blank) | T3N0M0 | IVA | Malignant | 3+4 | 2 | ||
B13 | 26 | - | - | - | - | - | - | - | - | - | ||
C1 | 27 | 71 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+4 | 2 | ||
C2 | 28 | 67 | M | Prostate | Adenocarcinoma | T3N1M0 | IVA | Malignant | 3+4 | 2 | ||
C3 | 29 | 62 | M | Prostate | Adenocarcinoma | T2N1M0 | IVA | Malignant | 3+4 | 2 | ||
C4 | 30 | 76 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C5 | 31 | 57 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C6 | 32 | 77 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C7 | 33 | 80 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C8 | 34 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C9 | 35 | 71 | M | Prostate | Adenocarcinoma | T2aN0M0 | IIB | Malignant | 3+4 | 2 | ||
C10 | 36 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | IIB | Malignant | 3+4 | 2 | ||
C11 | 37 | 75 | M | Prostate | Adenocarcinoma | T2aN0M0 | IIB | Malignant | 3+4 | 2 | ||
C12 | 38 | 73 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIB | Malignant | 4+3 | 3 | ||
C13 | 39 | - | - | - | - | - | - | - | - | - | ||
D1 | 40 | 68 | M | Prostate | Adenocarcinoma | - | - | Malignant | 3+4 | 3 | ||
D2 | 41 | 73 | M | Prostate | Adenocarcinoma | T2aN0M0 | IIIA | Malignant | 2+3 | 1 | ||
D3 | 42 | 58 | M | Prostate | Adenocarcinoma | - | - | Malignant | 4+3 | 3 | ||
D4 | 43 | 75 | M | Prostate | Adenocarcinoma | - | - | Malignant | 4+3 | 3 | ||
D5 | 44 | 76 | M | Prostate | Adenocarcinoma | - | - | Malignant | 4+3 | 3 | ||
D6 | 45 | 72 | M | Prostate | Adenocarcinoma | - | - | Malignant | 4+3 | 3 | ||
D7 | 46 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D8 | 47 | 65 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D9 | 48 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D10 | 49 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D11 | 50 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D12 | 51 | 61 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
D13 | 52 | - | - | - | - | - | - | - | - | - | ||
E1 | 53 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
E2 | 54 | 71 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
E3 | 55 | 64 | M | Prostate | Adenocarcinoma | T2aN0M0 | IIC | Malignant | 4+3 | 3 | ||
E4 | 56 | 60 | M | Prostate | Adenocarcinoma | T3N1M0 | IVA | Malignant | 4+3 | 3 | ||
E5 | 57 | 81 | M | Prostate | Adenocarcinoma | T3aN0M0 | IIIB | Malignant | 4+3 | 3 | ||
E6 | 58 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
E7 | 59 | 64 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+3 | 3 | ||
E8 | 60 | 80 | M | Prostate | Adenocarcinoma | T2N1M1c | IVB | Malignant | 4+3 | 3 | ||
E9 | 61 | 73 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIB | Malignant | 4+3 | 3 | ||
E10 | 62 | 76 | M | Prostate | Adenocarcinoma | T3N1M0 | IIIA | Malignant | 4+3 | 3 | ||
E11 | 63 | 78 | M | Prostate | Adenocarcinoma | T4N1M1b | IVB | Malignant | 4+3 | 3 | ||
E12 | 64 | 78 | M | Prostate | Adenocarcinoma | T3N2M1 | IVB | Malignant | 4+3 | 3 | ||
E13 | 65 | - | - | - | - | - | - | - | - | - | ||
F1 | 66 | 66 | M | Prostate | Adenocarcinoma (prostate tissue) | T2N0M0 | IIC | Malignant | - | - | ||
F2 | 67 | 75 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+4 | 4 | ||
F3 | 68 | 69 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+4 | 4 | ||
F4 | 69 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+4 | 4 | ||
F5 | 70 | 76 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIA | Malignant | 5+3 | 4 | ||
F6 | 71 | 66 | M | Prostate | Adenocarcinoma | T2N1M0 | IVA | Malignant | 5+3 | 4 | ||
F7 | 72 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIB | Malignant | 4+4 | 4 | ||
F8 | 73 | 71 | M | Prostate | Adenocarcinoma | - | - | Malignant | 4+4 | 4 | ||
F9 | 74 | 59 | M | Prostate | Adenocarcinoma | T4N0M0 | IIIB | Malignant | 4+4 | 4 | ||
F10 | 75 | 56 | M | Prostate | Adenocarcinoma | T2N1M0 | IVA | Malignant | 4+4 | 4 | ||
F11 | 76 | 64 | M | Prostate | Adenocarcinoma | T2N1M0 | IVA | Malignant | 4+4 | 4 | ||
F12 | 77 | 75 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+4 | 4 | ||
F13 | 78 | - | - | - | - | - | - | - | - | - | ||
G1 | 79 | 74 | M | Prostate | Adenocarcinoma | T2N0M0 | IIC | Malignant | 4+4 | 4 | ||
G2 | 80 | 60 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIB | Malignant | 4+4 | 4 | ||
G3 | 81 | 62 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIA | Malignant | 4+4 | 4 | ||
G4 | 82 | 70 | M | Prostate | Adenocarcinoma | - | - | Malignant | 5+5 | 5 | ||
G5 | 83 | 76 | M | Prostate | Adenocarcinoma | - | - | Malignant | 5+4 | 5 | ||
G6 | 84 | 63 | M | Prostate | Adenocarcinoma | - | - | Malignant | 5+4 | 5 | ||
G7 | 85 | 74 | M | Prostate | Adenocarcinoma | - | - | Malignant | 5+4 | 5 | ||
G8 | 86 | 59 | M | Prostate | Adenocarcinoma with neuroendocrine differentiation | - | - | Malignant | 5+4 | 5 | ||
G9 | 87 | 68 | M | Prostate | Adenocarcinoma | - | - | Malignant | 5+4 | 5 | ||
G10 | 88 | 61 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIC | Malignant | 5+4 | 5 | ||
G11 | 89 | 51 | M | Prostate | Adenocarcinoma | T4N0M0 | IIIC | Malignant | 5+4 | 5 | ||
G12 | 90 | 73 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 5+5 | 5 | ||
G13 | 91 | - | - | - | - | - | - | - | - | - | ||
H1 | 92 | 60 | M | Prostate | Adenocarcinoma | T3N1M1b | IVB | Malignant | 5+5 | 5 | ||
H2 | 93 | 61 | M | Prostate | Adenocarcinoma | T3N1M0 | IVA | Malignant | 5+5 | 5 | ||
H3 | 94 | 71 | M | Prostate | Adenocarcinoma | T3N1M0 | IVA | Malignant | 5+4 | 5 | ||
H4 | 95 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 4+5 | 5 | ||
H5 | 96 | 72 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 4+5 | 5 | ||
H6 | 97 | 76 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 5+4 | 5 | ||
H7 | 98 | 74 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 4+5 | 5 | ||
H8 | 99 | 65 | M | Prostate | Adenocarcinoma | T3bN0M0 | IIIC | Malignant | 5+4 | 5 | ||
H9 | 100 | 64 | M | Prostate | Adenocarcinoma (prostate tissue) | T2N0M0 | IIIC | Malignant | - | - | ||
H10 | 101 | 68 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 4+5 | 5 | ||
H11 | 102 | 66 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIC | Malignant | 5+5 | 5 | ||
H12 | 103 | 65 | M | Prostate | Adenocarcinoma (blank) | T3N1M0 | IVA | Malignant | - | - | ||
H13 | 104 | - | - | - | - | - | - | - | - | - | ||
I1 | 105 | 76 | M | Prostate | Adenocarcinoma | T3N0M0 | IIIC | Malignant | 4+5 | 5 | ||
I2 | 106 | 63 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 4+5 | 5 | ||
I3 | 107 | 60 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 5+5 | 5 | ||
I4 | 108 | 66 | M | Prostate | Adenocarcinoma | T2N0M0 | IIIC | Malignant | 5+5 | 5 | ||
I5 | 109 | 69 | M | Prostate | Leiomyosarcoma | T2N0M0 | IIB | Malignant | - | - | ||
I6 | 110 | 41 | M | Prostate | Leiomyosarcoma | T2N0M0 | IIB | Malignant | - | - | ||
I7 | 111 | 72 | M | Prostate | Leiomyosarcoma | T2N0M0 | IIB | Malignant | - | - | ||
I8 | 112 | 71 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
I9 | 113 | 79 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
I10 | 114 | 76 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
I11 | 115 | 84 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
I12 | 116 | 73 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
I13 | 117 | - | - | - | - | - | - | - | - | - | ||
J1 | 118 | 80 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
J2 | 119 | 28 | M | Prostate | Simple hyperplasia | - | - | Hyperplasia | - | - | ||
J3 | 120 | 73 | M | Prostate | Cancer adjacent prostate tissue | - | - | AT | - | - | ||
J4 | 121 | 68 | M | Prostate | Cancer adjacent prostate tissue | - | - | AT | - | - | ||
J5 | 122 | 66 | M | Prostate | Cancer adjacent prostate tissue | - | - | AT | - | - | ||
J6 | 123 | 72 | M | Prostate | Cancer adjacent prostate tissue | - | - | AT | - | - | ||
J7 | 124 | 72 | M | Prostate | Cancer adjacent prostate tissue | - | - | AT | - | - | ||
J8 | 125 | 35 | M | Prostate | Prostate tissue | - | - | Normal | - | - | ||
J9 | 126 | 35 | M | Prostate | Prostate tissue | - | - | Normal | - | - | ||
J10 | 127 | 36 | M | Prostate | Prostate tissue | - | - | Normal | - | - | ||
J11 | 128 | 29 | M | Prostate | Prostate tissue | - | - | Normal | - | - | ||
J12 | 129 | 47 | M | Prostate | Prostate tissue | - | - | Normal | - | - | ||
J13 | 130 | 28 | M | Prostate | Prostate tissue | - | - | Normal | - | - |
Find overlapping cases with this tissue array:
- Product Code: PR1211
- Availability: Out Of Stock